About
Aims
npj Precision Nutrition and Pharmacotherapy (NPJPNP) seeks to redefine the boundaries of clinical care by championing the convergence of nutritional science and pharmacological research through the lens of individual biological variability. The journal’s primary aim is to foster a comprehensive understanding of how specific dietary patterns and bioactive nutrients interact with pharmacological agents at the molecular and cellular levels. By prioritizing research that employs a systems-biology approach, NPJPNP aims to move beyond 'one-size-fits-all' paradigms toward a future where therapeutic interventions are tailored to the unique genetic, epigenetic, and metabolic profile of every patient. We strive to be the leading venue for interdisciplinary discovery that accelerates the translation of basic multi-omics data into actionable clinical protocols, ultimately improving patient outcomes in chronic disease prevention and management.
Scope
NPJPNP publishes high-quality research exploring the intricate relationships between human biology, external nutritional inputs, and therapeutic drugs. We are particularly interested in studies that utilize high-resolution data to explain variance in health outcomes. Our scope includes, but is not limited to, the following areas:
• Multi-Omics Integration: Research utilizing genomics, transcriptomics, proteomics, and metabolomics to map individual responses to nutrients and drugs.
• Pharmacometabolomics and Nutrigenetics: Investigations into how genetic polymorphisms and metabolic signatures influence the efficacy and toxicity of pharmacological treatments.
• Microbiome-Mediated Interactions: Research on the gut microbiota’s role in biotransforming drugs and nutrients and the subsequent impact on systemic bioavailability.
• Synergistic Personalized Therapy: Exploring the concurrent use of targeted nutritional interventions and pharmaceutical agents to enhance therapeutic indices.
• Computational Phenotyping: The development of machine learning and artificial intelligence models to predict individualized responses to complex diet-drug regimens.
• Epigenetic Modulation: How bioactive food components influence gene expression through DNA methylation and histone modification, affecting drug response pathways.
• Molecular Food-Drug Interactions (FDI): Detailed mechanistic studies on the interference or enhancement of drug pathways by specific dietary compounds.
• Clinical Precision Trials: Pilot and longitudinal studies focusing on N-of-1 designs and personalized metabolic monitoring in diverse patient populations.
Article Types
• Research Articles: Original, full-length reports of innovative scientific findings.
• Review Articles: Comprehensive syntheses of current knowledge in specific sub-fields of precision health.
• Brief Communications: Rapid reports of high-impact preliminary data or novel methodologies.
• Perspectives: Forward-looking essays discussing emerging trends and future directions in the field.
• Clinical Case Reports: Detailed accounts of individualized treatment outcomes that provide broader mechanistic insights.
• Data Descriptors: Descriptions of large-scale multi-omics datasets available for the scientific community.
Audience
The journal serves an international community of researchers and practitioners, including molecular biologists, pharmacologists, geneticists, clinical nutritionists, and computational biologists. It is also a vital resource for healthcare policy makers and industry stakeholders involved in the development of personalized diagnostic tools and therapeutic products.